In the tumor microenvironment, FBXO38 deficiency led to elevated PD-1 levels and impaired T-cell functions, resulting in accelerated tumor progression in melanoma and colorectal cancer models (Fig. 3d–l and Fig. S6 of (Meng et al, 2018)). The gene discussed is FBXO38; the disease is neoplasm.